During the past decade, Upstate Carolina CCOP conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Upstate Carolina CCOP" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "SWOG Cancer Research Network" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Academic and Community Cancer Research United" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Upstate Carolina CCOP" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Upstate Carolina CCOP" are "Recurrent Melanoma" (2 trials), "Stage IV Melanoma" (2 trials), "Acral Lentiginous Malignant Melanoma" (1 trials), "Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome" (1 trials) and "Adenocarcinoma of the Colon" (1 trials). Many other conditions were trialed in "Upstate Carolina CCOP" in a lesser frequency.

Most popular intervention types in "Upstate Carolina CCOP" are "Drug" (19 trials), "Biological" (8 trials), "Other" (7 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "fluorouracil" (4 trials), "leucovorin calcium" (4 trials), "Bevacizumab" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Upstate Carolina CCOP" are 16 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Upstate Carolina CCOP". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Upstate Carolina CCOP, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Upstate Carolina CCOP, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".